Physician profile
Gretchen E Farmer
NPI 1720283450
$6,293.25
in general payments reported to CMS, 2019-2025
42 companies · $1,044 in 2025
The $1,044 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $730 · 2020: $547 · 2021: $913 · 2022: $705 · 2023: $1,177 · 2024: $1,177 · 2025: $1,044.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,321 · Education: $77.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,320.69 |
| Education | $77.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,271.04 | 2021-2025 | |
| Novo Nordisk INC | $966.10 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $437.81 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Pfizer INC. | $335.88 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $295.05 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Supernus Pharmaceuticals, INC. | $284.12 | 2019-2024 | Qelbree, Qelbree |
| Lilly USA, LLC | $282.68 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Otsuka America Pharmaceutical, INC. | $247.49 | 2022-2025 | Rexulti |
| Glaxosmithkline, LLC. | $225.20 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Amgen INC. | $214.01 | 2019-2025 | Prolia, Evenity, Repatha |
| Tris Pharma INC | $199.98 | 2019-2025 | Dyanavel Xr |
| Dexcom, INC. | $129.21 | 2021-2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $122.98 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Ironshore Pharmaceuticals INC. | $109.72 | 2019-2024 | Jornay Pm |
| Collegium Pharmaceutical, INC. | $93.51 | 2025 | Jornay Pm |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gretchen Farmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.